News

FDA approves first blood test to help screen for Alzheimer's disease
The Lumipulse G Plasma Ratio Test offers a new way to detect signs of Alzheimer's disease by identifying plaque proteins in ...
The American Journal of Managed Care1h
FDA Clears First Blood Test for Early Detection of Alzheimer-Linked Amyloid Plaques
The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.
WKTV NewsChannel 21h
FDA Greenlights First Blood Test to Help Diagnose Alzheimer’s Disease in the US
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
BioSpace3h
FDA Clears First Alzheimer’s Blood Test, Lending ‘Momentum’ to Lilly’s Kisunla, Biogen’s Leqembi
Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...
Medical Device Network on MSN7h
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
InsideHook on MSN19h
The FDA Just Approved an Alzheimer's Disease Blood Test
If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...
Press Enterprise Online1d
FDA clears blood test to detect Alzheimer’s
WASHINGTON (USA TODAY Network) — The Food and Drug Administration said Friday it cleared the first blood test for Alzheimer’s. The Lumipulse blood plasma test ...
FDA clears first blood test to diagnose Alzheimer’s disease
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
FDA greenlights marketing of first Alzheimer's blood test for some patients
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
New Alzheimer's Test Approved by FDA—What to Know
The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...
FDA greenlights first blood test to diagnose Alzheimer's disease
FDA approves Lumipulse G, the first blood test that can help in the diagnosis of Alzheimer's disease. Read more here.
FDA clears first blood test to detect Alzheimer's disease. What to know about Lumipulse.
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.